Founded in 1941 in Tokyo as an optical glass production plant, Hoya is one of the largest eyeglass lens manufacturers in the world... Show more
HOCPF saw its Momentum Indicator move below the 0 level on November 26, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 75 similar instances where the indicator turned negative. In of the 75 cases, the stock moved further down in the following days. The odds of a decline are at .
The Moving Average Convergence Divergence Histogram (MACD) for HOCPF turned negative on November 19, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
HOCPF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 199 cases where HOCPF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HOCPF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HOCPF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.190) is normal, around the industry mean (9.233). P/E Ratio (40.059) is within average values for comparable stocks, (163.343). Projected Growth (PEG Ratio) (3.779) is also within normal values, averaging (2.548). Dividend Yield (0.010) settles around the average of (0.016) among similar stocks. P/S Ratio (9.208) is also within normal values, averaging (110.831).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Industry PharmaceuticalsOther
A.I.dvisor tells us that HOCPF and AXGN have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HOCPF and AXGN's prices will move in lockstep.
| Ticker / NAME | Correlation To HOCPF | 1D Price Change % | ||
|---|---|---|---|---|
| HOCPF | 100% | N/A | ||
| AXGN - HOCPF | 25% Poorly correlated | -3.03% | ||
| HOCPY - HOCPF | 25% Poorly correlated | N/A | ||
| SHWGY - HOCPF | 24% Poorly correlated | N/A | ||
| TIVC - HOCPF | 20% Poorly correlated | -3.28% | ||
| FZMD - HOCPF | 4% Poorly correlated | N/A | ||
More | ||||
| Ticker / NAME | Correlation To HOCPF | 1D Price Change % |
|---|---|---|
| HOCPF | 100% | N/A |
| Pharmaceuticals category (377 stocks) | 9% Poorly correlated | +0.67% |
| Pharmaceuticals: Other category (103 stocks) | 6% Poorly correlated | +0.77% |